Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects will be eligible for study enrollment if they: are adolescents between the ages of 13 and 17 years~* have a confirmed diagnosis of schizophrenia and are suffering from an acute episode~* provide their assent and parental informed consent to participate~* are otherwise relatively healthy on the basis of a medical and physical examination~* and are able to be in-patients for approximately 2 weeks.~Exclusion Criteria:~* Subjects will be excluded from the study if they: meet the criteria for psychiatric disorders other than schizophrenia~* have moderate or severe mental retardation~* fail to respond to treatment with at least two typical or atypical antipsychotics~* have a history of substance dependence within the 3 months before screening~* are considered at risk for suicidal or violent behavior~* have a seizure disorder~* have a history of neuroleptic malignant syndrome, similar encephalopathic syndrome, or tardive dyskinesia~* or receive prohibited medication within a specified period before screening.

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).